{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cucurbitaceae", "allergy", "herbal medicine", "inflammation", "ovalbumin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35257554", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.15586/aei.v50i2.577"], "Journal": {"ISSN": "1578-1267", "JournalIssue": {"Volume": "50", "Issue": "2", "PubDate": {"Year": "2022"}}, "Title": "Allergologia et immunopathologia", "ISOAbbreviation": "Allergol Immunopathol (Madr)"}, "ArticleTitle": "<i>Momordica charantia</i> L. improves airway hyperresponsiveness and suppresses inflammation in a murine model of allergic asthma.", "Pagination": {"StartPage": "115", "EndPage": "123", "MedlinePgn": "115-123"}, "Abstract": {"AbstractText": ["To evaluate the effect of a hydroethanolic extract of <i>Momordica charantia</i> L. (\"bitter melon\", Cucurbitaceae) leaves (MCHA) on ovalbumin (OVA)-induced asthma model. Balb/c mice were sensitized twice and challenged for 4 alternate days with OVA and then treated with MCHA (500 mg/kg) for 7 consecutive days.", "Control groups received treatment with normal saline or dexamethasone (2 mg/kg) on the same day. We assessed <i>in vivo</i> bronchial hyperresponsiveness and <i>ex-vivo</i> inflammation and mucus production in bronchoalveolar lavage (BAL), lung homogenates, and lung tissue.", "MCHA significantly improved airway hyperresponsiveness near baseline levels. MCHA administration significantly improved airway and lung inflammation, demonstrated by decreased total and inflammatory cells in BAL, lower levels of IL-5 and IL-13 in lung homogenate, and fewer inflammatory cells in lung tissue. Additionally, MCHA significantly diminished goblet cells in lung tissue.", "Administration of a hydroethanolic extract of <i>M. charantia</i> leaves was effective in treating OVA-induced asthma in an animal model."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Frota", "ForeName": "Clara do Prado Lopes", "Initials": "CDPL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Ribeiro", "ForeName": "Alessa Castro", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Filho", "ForeName": "Marco T\u00falio Alvarenga Calil", "Initials": "MTAC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Biotechnology, University of Ribeirao Preto, Ribeirao Preto, Brazil."}], "LastName": "Morel", "ForeName": "Lucas Junqueira de Freitas", "Initials": "LJF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Ramalho", "ForeName": "Leandra Naira Zambelli", "Initials": "LNZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Federal University of Sao Carlos, S\u00e3o Carlos, Brazil."}], "LastName": "Amaral", "ForeName": "J\u00e9ssica Cristina", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Biotechnology, University of Ribeirao Preto, Ribeirao Preto, Brazil."}], "LastName": "Contini", "ForeName": "Silvia Helena Taleb", "Initials": "SHT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "da Fonseca", "ForeName": "Vanessa Maciel Braulio", "Initials": "VMB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Borges", "ForeName": "Marcos de Carvalho", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Biotechnology, University of Ribeirao Preto, Ribeirao Preto, Brazil."}, {"Identifier": [], "Affiliation": "Botanical Garden of Medicinal Plants Ordem e Progresso, Jardinopolis, Brazil."}], "LastName": "Pereira", "ForeName": "Ana Maria Soares", "Initials": "AMS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil; carmona@fmrp.usp.br."}], "LastName": "Carmona", "ForeName": "Fabio", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Allergol Immunopathol (Madr)", "NlmUniqueID": "0370073", "ISSNLinking": "0301-0546"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "9006-59-1", "NameOfSubstance": "Ovalbumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Asthma"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Momordica charantia"}, {"QualifierName": [], "DescriptorName": "Ovalbumin"}], "CoiStatement": "The authors declare no potential conflicts of interest with respect to research, authorship and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "1. Global Initiative for Asthma. Global strategy for asthma management and prevention. [cited 2020]. Availavle from: http://www.ginasthma.org", "ArticleIdList": [""]}, {"Citation": "2. Cruz AA, Pizzichini ALGFE, Fiterman J, Jones LFFPMMMPM, Lima MA, Stirbulo PAMCR. Diretrizes da sociedade brasileira de pneumologia e tisiologia para o manejo da asma-2012. J Bras Pneumol Tisiol. 2012;38:S1-46.", "ArticleIdList": [""]}, {"Citation": "3. The Plant List. [cited 2021]. Available from: http://www.theplantlist.org", "ArticleIdList": [""]}, {"Citation": "4. Dandawate PR, Subramaniam D, Padhye SB, Anant S. Bitter melon: a panacea for inflammation and cancer. Chin J Nat Med. 2016;14(2):81\u2013100. 10.1016/S1875-5364(16) 60002-X", "ArticleIdList": ["10.1016/S1875-5364(16)"]}, {"Citation": "5. Bortolotti M, Mercatelli D, Polito L. Momordica charantia, a nutraceutical approach for inflammatory related diseases. Front Pharmacol. 2019;10:1\u20139. 10.3389/fphar.2019.00486", "ArticleIdList": ["10.3389/fphar.2019.00486"]}, {"Citation": "6. Zhang J, Huang Y, Kikuchi T, Tokuda H, Suzuki N, Inafuku K, et al. Cucurbitane triterpenoids from the leaves of momordica charantia, and their cancer chemopreventive effects and cytotoxicities. Chem Biodivers. 2012;9(2):428\u201340. http://doi.wiley.com/10.1002/cbdv.201100142", "ArticleIdList": [""]}, {"Citation": "7. Ma J, Krynitsky AJ, Grundel E, Rader JI. Quantitative determination of cucurbitane-type triterpenes and Triterpene Glycosides in dietary supplements containing bitter melon (Momordica charantia) by HPLC-MS/MS. J AOAC Int. 2012;95 (6):1597\u20131608. https://academic.oup.com/jaoac/article/95/6/1597-1608/5655273", "ArticleIdList": [""]}, {"Citation": "8. Chanda J, Mukherjee PK, Biswas R, Malakar D, Pillai M. Study of pancreatic lipase inhibition kinetics and LC-QTOF-MS based identification of bioactive constituents of Momordica charantia fruits. Biomed Chromatogr. 2018;e4463. https://onlinelibrary.wiley.com/doi/abs/10.1002/bmc.4463", "ArticleIdList": [""]}, {"Citation": "9. Azevedo BC, Morel LJF, Carmona F, Cunha TM, Contini SHT, Delprete PG, et al. Aqueous extracts from Uncaria tomentosa (Willd. ex Schult.) DC. reduce bronchial hyperresponsiveness and inflammation in a murine model of asthma. J Ethnopharmacol. 2018;218:76\u201389. http://linkinghub.elsevier.com/retrieve/pii/S0378874117334566", "ArticleIdList": [""]}, {"Citation": "10. de Freitas Morel LJ, de Azevedo BC, Carmona F, Contini SHT, Teles AM, Ramalho FS, et al. A standardized methanol extract of Eclipta prostrata (L.) L. (Asteraceae) reduces bronchial hyperresponsiveness and production of Th2 cytokines in a murine model of asthma. J Ethnopharmacol. 2017;198:226\u201334. http://linkinghub.elsevier.com/retrieve/pii/S0378874116323121", "ArticleIdList": [""]}, {"Citation": "11. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277\u201385. https://pubmed.ncbi.nlm.nih.gov/15003729/", "ArticleIdList": [""]}, {"Citation": "12. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol. 1999;162(10):6284\u201393. https://www.jimmunol.org/content/162/10/6284.short", "ArticleIdList": [""]}, {"Citation": "13. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258\u201361. https://www.science.org/doi/abs/10.1126/science.282.5397.2258", "ArticleIdList": [""]}, {"Citation": "14. Krawinkel MB, Keding GB. Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia. Nutr Rev. 2006;64:331\u20137. http://www.ncbi.nlm.nih.gov/pubmed/16910221", "ArticleIdList": [""]}, {"Citation": "15. El Batran SAES, El-Gengaihi SE, El Shabrawy OA. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol. 2006;108(2):236\u201342. http://www.ncbi.nlm.nih.gov/pubmed/16815658", "ArticleIdList": [""]}, {"Citation": "16. Yang SJ, Choi JM, Park SE, Rhee EJ, Lee WY, Oh KW, et al. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-\u03baB and JNK pathways in high-fat-fed OLETF rats. J Nutr Biochem. 2015;26(3):234\u201340. http://www.sciencedirect.com/science/article/pii/S095528631400237X", "ArticleIdList": [""]}, {"Citation": "17. Rahman IU, Khan RU, Rahman KU, Bashir M. Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients. Nutr J. 2015;14(1): 13. http://ezproxy.think.edu.au/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=25504465&site=ehost-live&scope=site&custid=s8454151", "ArticleIdList": [""]}, {"Citation": "18. Kim SK, Jung J, Jung JH, Yoon N, Kang SS, Roh GS, et al. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus. Complement Ther Med. 2020;52:102524. https://linkinghub.elsevier.com/retrieve/pii/S0965229920302491", "ArticleIdList": [""]}, {"Citation": "19. Cortez-Navarrete M, Mart\u00ednez-Abundis E, P\u00e9rez-Rubio KG, Gonz\u00e1lez-Ortiz M, M\u00e9ndez-del Villar M. Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus. J Med Food. 2018;21(7):672\u201377. http://www.liebertpub.com/doi/10.1089/jmf.2017.0114", "ArticleIdList": [""]}, {"Citation": "20. Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, et al. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: systematic review and meta-analysis. J Ethnopharmacol. 2019;231:311\u201324. 10.1016/j.jep.2018.10.033", "ArticleIdList": ["10.1016/j.jep.2018.10.033"]}, {"Citation": "21. Jia S, Shen M, Zhang F, Xie J. Recent advances in momordica charantia: functional components and biological activities. Int J Mol Sci. 2017;18(12). 2555 https://www.mdpi.com/1422-0067/18/12/2555", "ArticleIdList": [""]}, {"Citation": "22. Soo May L, Sanip Z, Ahmed Shokri A, Abdul Kadir A, Md Lazin MR. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: a single-blinded, randomized controlled trial. Complement Ther Clin Pract. 2018;32:181\u20136. https://linkinghub.elsevier.com/retrieve/pii/S1744388118301701", "ArticleIdList": [""]}, {"Citation": "23. Liaw C, Huang H, Hsiao P, Zhang L, Lin Z, Hwang S, et al. 5\u03b2,19-Epoxycucurbitane Triterpenoids from Momordica charantia and their anti-inflammatory and cytotoxic activity. Planta Med. 2015;81(1):62\u201370. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1383307", "ArticleIdList": [""]}, {"Citation": "24. Chao C-Y, Sung P-J, Wang W-H, Kuo Y-H. Anti-inflammatory effect of momordica charantia in sepsis Mice. Molecules. 2014; 19:12777\u201388. http://www.mdpi.com/1420-3049/19/8/12777/", "ArticleIdList": [""]}, {"Citation": "25. Shivanagoudra SR, Perera WH, Perez JL, Athrey G, Sun Y, Wu CS, et al. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L. Bioorganic Med Chem. 2019;27(14):3097\u2013109. 10.1016/j.bmc.2019.05.035", "ArticleIdList": ["10.1016/j.bmc.2019.05.035"]}, {"Citation": "26. Kobori M, Nakayama H, Fukushima K, Ohnishi-Kameyama M, Ono H, Fukushima T, et al. Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses. J Agric Food Chem. 2008;56(11):4004\u201311. http://www.ncbi.nlm.nih.gov/pubmed/18489106", "ArticleIdList": [""]}, {"Citation": "27. Lii C-K, Chen H-W, Yun W-T, Liu K-L. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW 264.7 macrophages. J Ethnopharmacol. 2009;122(2):227\u20133. http://www.ncbi.nlm.nih.gov/pubmed/19330915", "ArticleIdList": [""]}, {"Citation": "28. Nhiem NX, Yen PH, Ngan NTT, Quang TH, Kiem P Van, Minh C Van, et al. Inhibition of nuclear transcription factor-\u03baB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia. J Med Food. 2012;15(4):369\u2013377. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308713&tool=pmcentrez&rendertype=abstract", "ArticleIdList": [""]}, {"Citation": "29. Hogan SP. Recent advances in eosinophil biology. Int Arch Allergy Immunol. 2007;143:3\u201314. https://www.karger.com/Article/Abstract/101398", "ArticleIdList": [""]}, {"Citation": "30. van Rensen ELJ, Evertse CE, van Schadewijk WAAM, van Wijngaarden S, Ayre G, Mauad T, et al. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment. Allergy. 2009;64(1):72\u201380. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1398-9995.2008.01881.x", "ArticleIdList": [""]}, {"Citation": "31. Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 2014;5:1\u201317. 10.3389/fimmu.2014.00570", "ArticleIdList": ["10.3389/fimmu.2014.00570"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "1"}, {"Year": "2022", "Month": "1", "Day": "27"}, {"Year": "2022", "Month": "3", "Day": "8", "Hour": "5", "Minute": "43"}, {"Year": "2022", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "7", "Hour": "6", "Minute": "0"}], "PublicationStatus": "epublish", "ArticleIdList": ["35257554", "10.15586/aei.v50i2.577"]}}], "PubmedBookArticle": []}